Obagi C Rx Clarifying Serum - Normal to Oily
Obagi-C Rx C-Clarifying Serum contains 4% hydroquinone plus 10% Vitamin C and is delivered into the deepest layers of your skin. Rx-only hydroquinone lightens skin by reducing melanosome activity. Pure Vitamin C provides strong anti-oxidant protection and brightens skin. For Normal to Oily Skin
Hydroquinone Plus Vitamin C: A Winning Combination
Obagi-C Rx C-Clarifying Serum contains 4% hydroquinone plus 10% pure vitamin C. Hydroquinone lightens skin by reducing melanosome activity and preps the skin for the deep absorption of Vitamin C. Ideal for normal to dry complexions, this serum helps even out skin tone and lighten hyperpigmentation.
With Obagi-C Rx, you’re on your way to softer, smoother, radiant, and more even-looking skin. The Obagi-C Rx System offers the benefits of both prescription-strength 4% hydroquinone and 10% pure Vitamin C (L-ascorbic acid) to address the signs of skin damage and help obtain and maintain younger-looking skin.
Obagi-C Rx System products are ideal if you have:
- Minimal fine lines and wrinkles
- Mild to moderate unevenness of skin tone
- Mild to moderate discoloration and age spots
- For normal to oily skin
Contains 10% pure Vitamin C.
Contains 4% hydroquinone. Use sunscreen when exposed to sun.
Hydroquinone CONTRAINDICATIONS: People with prior history of sensitivity or allergic reaction to this product or any of its ingredients should not use it. The safety of topical hydroquinone use during pregnancy or in children (12 years and under) has not been established. WARNINGS: Avoid contact with eyes, nose, mouth, or lips. In case of accidental contact, patient should rinse eyes, nose, mouth, or lips with water and contact physician. Sunscreen use is an essential aspect of hydroquinone therapy because even minimal sunlight exposure sustains melanocytic activity. Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people. PRECAUTIONS: Treatment should be limited to relatively small areas of the body at one time since some patients experience a transient skin reddening and a mild burning sensation, which does not preclude treatment.
Pregnancy Category C: Animal reproduction studies have not been conducted with topical hydroquinone. It is also not known whether hydroquinone can cause fetal harm when used topically on a pregnant woman or affect reproductive capacity. It is not known to what degree if any, topical hydroquinone is absorbed systemically. Topical hydroquinone should be used on pregnant women only when clearly indicated.
Nursing Mothers: It is not known whether topical hydroquinone is absorbed or excreted in human milk. Caution is advised when topical hydroquinone is used by a nursing mother.
Pediatric Usage: Safety and effectiveness in children below the age of 12 years have not been established. Use of the product should be discontinued if hypersensitivity to any of the ingredients is noted.